Literature DB >> 9177660

Glaucoma therapy may take your breath away.

P Diggory1, W A Franks.   

Abstract

Chronic simple glaucoma is a common disease in old age and lowering intraocular pressure is the treatment strategy. Although this can be achieved surgically, medical treatment with eye drops is more often prescribed. Beta-antagonists are the class of drug most often chosen, although other medical therapies are available. Systemic absorption of beta-antagonist eye drops can cause unsuspected respiratory impairment. Physicians should be alert to the possibility of respiratory side-effects of topical therapy with beta-antagonists and whenever such side-effects occur should use alternative treatments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177660     DOI: 10.1093/ageing/26.2.63

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  6 in total

1.  Prevalence of open-angle glaucoma among adults in the United States.

Authors:  David S Friedman; Roger C W Wolfs; Benita J O'Colmain; Barbara E Klein; Hugh R Taylor; Shelia West; M Cristina Leske; Paul Mitchell; Nathan Congdon; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

2.  Patients' perception of visual impairment in glaucoma: a pilot study.

Authors:  P Nelson; P Aspinall; C O'Brien
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

Review 3.  Travoprost.

Authors:  John Waugh; Blair Jarvis
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  The incidence of prescribing errors in an eye hospital.

Authors:  K Mandal; S G Fraser
Journal:  BMC Ophthalmol       Date:  2005-03-22       Impact factor: 2.209

5.  Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users.

Authors:  Wishal D Ramdas; Nathalie van der Velde; Tischa J M van der Cammen; Roger C W Wolfs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-19       Impact factor: 3.117

6.  Effects of Mirtogenol on ocular blood flow and intraocular hypertension in asymptomatic subjects.

Authors:  Robert D Steigerwalt; Belcaro Gianni; Morazzoni Paolo; Ezio Bombardelli; Carolina Burki; Frank Schönlau
Journal:  Mol Vis       Date:  2008-07-10       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.